Both deliver the same molecule. Glutathione injections are a small dose at home on a schedule your clinician sets; an IV drip is a clinic appointment with a needle in a vein. Here is the honest comparison.
No FDA-approved GLP-1 patch exists. The patches sold online list plant ingredients such as berberine, not a GLP-1 drug. Here is what is in them and how weekly GLP-1 shots compare.
Both prompt your pituitary to release more of its own growth hormone. Only one is prescribed after a physician review and prepared by a licensed U.S. pharmacy. Here is the honest comparison, and how our clinicians weigh it.
Social media calls berberine "nature's Ozempic." It is a plant compound sold as a supplement, and it does not work like semaglutide. Here is what the evidence shows for weight and blood sugar.
One is an approved medication you can start this month. The other is a promising investigational drug still working through phase 3. Here is how they compare, and what the retatrutide headlines leave out.
Two peptides that both prompt your pituitary to release its own growth hormone, through two different receptors, with very different regulatory records. Here is the honest comparison, and how our clinicians think about it.
Both are weekly GLP-1 pens for type 2 diabetes, from different makers and with different molecules. One trial put them head to head. Here is what it found, and what it did not test.
They share an active ingredient and very little else: regulatory status, trial evidence, delivery and price all differ. Here is the honest comparison, and how to decide which one fits your situation.
NMN and NR are building blocks you buy and dose yourself. NAD+ is the finished coenzyme, prescribed after a physician's review and prepared by a pharmacy for you. Here is the honest comparison.
One is a decades-old stimulant pill meant for a few weeks. The other is a weekly GLP-1 built for long-term treatment. Here is how they compare on results, safety, duration and cost.
Two growth-hormone-releasing peptides that work through the same pathway, with very different approvals, evidence and access. Here is how they compare, and how Arbor's clinicians think about the choice.
One route puts NAD+ into a vein over hours in a clinic. The other is a small shot at home on a schedule your clinician sets. Here is the honest comparison on time, cost and comfort, and how our clinicians choose between the two.